Contrasting Inspire Medical Systems (NYSE:INSP) and Nemaura Medical (NASDAQ:NMRD)

Inspire Medical Systems (NYSE:INSP) and Nemaura Medical (NASDAQ:NMRD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Institutional and Insider Ownership

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Inspire Medical Systems and Nemaura Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$802.80 million	6.54	$53.51 million	$1.73	102.24
Nemaura Medical	$80,000.00	0.00	-$14.14 million	($0.39)	N/A

Inspire Medical Systems has higher revenue and earnings than Nemaura Medical. Nemaura Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for Inspire Medical Systems and Nemaura Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0	3	8	0	2.73
Nemaura Medical	0	0	0	0	0.00

Inspire Medical Systems presently has a consensus target price of $228.82, suggesting a potential upside of 29.37%. Given Inspire Medical Systems’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Nemaura Medical.

Volatility and Risk

Inspire Medical Systems has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500.

Profitability

This table compares Inspire Medical Systems and Nemaura Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	6.67%	8.19%	7.09%
Nemaura Medical	N/A	N/A	N/A

Summary

Inspire Medical Systems beats Nemaura Medical on 11 of the 12 factors compared between the two stocks.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.